WG Biotech ApS: Financial statements 2019
CVR: 36940131
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
WG Biotech ApS (CVR 36940131) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 389,482,000 compared with DKK 657,459,000 the year before. Equity in the 2019 report amounted to DKK 1,141,674,000. The solvency ratio was 99.3%.
- Profit/Loss
- DKK 389,482,000
- Equity
- DKK 1,141,674,000
- Total Assets
- DKK 1,149,178,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | 389.5 mio. | 1.1 mia. | - |
| 2018 | - | - | 657.5 mio. | 657 mio. | - |
| 2017 | - | - | -220 t. | -425 t. | - |
| 2016 | - | - | -265 t. | -204 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
WG Biotech ApS has published its annual report for 2018. The net result was DKK 657,459,000.
About WG Biotech ApS
WG Biotech ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2015. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Johan Ernst Wedell-Wedellsborg. The company is owned by WECO A/S and WG Biotech ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,963,000 and a net result of DKK 2,166,000 compared with DKK 48,534,000 the year before. Equity in the 2025 report amounted to DKK 311,608,000.